Merrill Lynch, Pierce, Fenner & S recently announced the acquisition of new stake in National Health Investors Inc. (NYSE:NHI). The institutional investor has increased its shareholding in the Real Estate company by 0.84% to 0.74 million shares with purchase of 6208.0 shares. This fresh investment now brings its stake to 1.72% valued currently at $38.85 million. In addition, American Century Investment Manag raised its holdings by 21310.0 to 0.73 million shares. And Dimensional Fund Advisors LP has lifted its position by 0.58% or 3543.0 shares – to 0.62 million shares.
With over 0.25 million National Health Investors Inc. (NHI) shares trading Friday and a closing price of $55.15 on the day, the dollar volume was approximately $13.52 million. The shares have shown a negative half year performance of -9.38% and its price on 01/13/23 lost nearly -0.18%. Currently, there are 44.34M common shares owned by the public and among those 41.32M shares have been available to trade.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 6 analysts who have offered their price forecasts for NHI have a consensus price objective of $60.83. The analysts have set the share’s price value over the next 12 months at a high of $68.00 and a low of $55.00. The average price target is 9.34% above its recent price level and a downside to the estimated low will see the stock lose -0.27% over that period. But an upside of 18.9% will see the stock hit the forecast high price target while median target price for the stock is $59.00.
Insiders at the company have transacted a total of 4 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 3 of these insider trades were purchases, accounting for 20,833 shares. Insider sales of the common stock occurred on 1 occasions, with total insider shares sold totaling 16,065 shares.
The top 3 mutual fund holders in National Health Investors Inc. are Vanguard Real Estate Index Fund, Vanguard Total Stock Market Index, and Vanguard Small Cap Index Fund. Vanguard Real Estate Index Fund owns 2.02 million shares of the company’s stock, all valued at over $105.26 million. The company sold 61787.0 shares recently to bring their total holdings to about 4.65% of the shares outstanding. Vanguard Total Stock Market Index bought 1725.0 shares to see its total holdings expand to 1.28 million shares valued at over $66.59 million and representing 2.94% of the shares outstanding. Vanguard Small Cap Index Fund bought 90.0 shares to bring its total holdings to over 1.09 million shares at a value of $57.17 million. Vanguard Small Cap Index Fund now owns shares totaling to 2.52% of the shares outstanding.
Shares of National Health Investors Inc. (NYSE: NHI) opened at $54.96, down -$0.29 from a prior closing price of $55.25. However, the script later moved the day high at 55.42, down -0.18%. The company’s stock has a 5-day price change of 1.79% and 4.06% over the past three months. NHI shares are trading 5.61% year to date (YTD), with the 12-month market performance down to -6.29% lower. It has a 12-month low price of $50.22 and touched a high of $67.16 over the same period. NHI has an average intraday trading volume of 247.39K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.29%, 0.62%, and -5.10% respectively.
Institutional ownership of National Health Investors Inc. (NYSE: NHI) shares accounts for 64.80% of the company’s 44.34M shares outstanding. Mutual fund holders own 39.16%, while other institutional holders and individual stakeholders account for 7.36% and 25.50% respectively.
It has a market capitalization of $2.40B and a beta (3y monthly) value of 0.91. The stock’s trailing 12-month PE ratio is 35.02, while the earnings-per-share (ttm) stands at $1.57. The company has a PEG of 3.50 and the debt-to-equity ratio at 0.85. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.06% over the week and 2.32% over the month.
Analysts forecast that National Health Investors Inc. (NHI) will achieve an EPS of $0.77 for the current quarter, $0.7 for the next quarter and $3.33 for 2023. The lowest estimate earnings-per-share for the quarter is $0.77 while analysts give the company a high EPS estimate of $0.77. Comparatively, EPS for the current quarter was $0.67 a year ago. Earnings per share for the fiscal year are expected to decrease by -41.00%, and 35.94% over the next financial year. EPS should grow at an annualized rate of 10.00% over the next five years, compared to -8.80% over the past 5-year period.
Looking at the support for the NHI, a number of firms have released research notes about the stock. Credit Suisse stated their Neutral rating for the stock in a research note on December 09, 2022, with the firm’s price target at $47-$58. BMO Capital Markets coverage for the National Health Investors Inc. (NHI) stock in a research note released on June 21, 2022 offered a Market Perform rating with a price target of $62. CapitalOne was of a view on June 03, 2022 that the stock is Overweight, while Credit Suisse gave the stock Underperform rating on February 01, 2022, issuing a price target of $51. BMO Capital Markets on their part issued Outperform rating on January 07, 2022.
